The genetics of kidney transplantation

被引:7
作者
Pallet, Nicolas [1 ,2 ]
Thervet, Eric [1 ,2 ]
机构
[1] Univ Paris 05, Ctr Univ Saints Peres, INSERM, U775, F-75006 Paris, France
[2] Univ Paris 05, Hop Europeen Georges Pompidou, Serv Nephrol, F-75006 Paris, France
关键词
RENAL-TRANSPLANTATION; DIABETES-MELLITUS; MYCOPHENOLIC-ACID; ACUTE REJECTION; RISK-FACTORS; GRAFT LOSS; FOLLOW-UP; RECIPIENTS; POLYMORPHISMS; CYCLOSPORINE;
D O I
10.1007/s00439-011-1092-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Over the last decade, the search for gene variants with the potential to influence transplant outcomes or predispose individuals to host-recipient-related phenotypes has generated a considerable number of studies with conflicting results. Thousands of genotypes have been associated with complex traits related to transplant medicine, including acute rejection, immunosuppressive drug metabolism and side effects, infections, long-term outcomes, and cardiovascular complications. However, these efforts have given disappointing results, both in terms of gaining understanding of the biological basis of disease and in patient management. The methodological weaknesses that constitute the major limitations of most of these studies have been discussed widely. A new generation of approaches is needed to understand the relationship between gene variants and complex kidney transplantation traits. These approaches should be global, to generate original pathophysiological hypotheses, and should rely on advanced genomic tools, including Genome Wide Association studies and Whole Genome Sequencing technologies. Such enterprises will only be successful with the creation of international consortiums that connect partners in clinical, industrial, and academic transplant medicine.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 48 条
  • [1] Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction
    Anglicheau, D.
    Pallet, N.
    Rabant, M.
    Marquet, P.
    Cassinat, B.
    Meria, P.
    Beaune, P.
    Legendre, C.
    Thervet, E.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (06) : 1019 - 1025
  • [2] Cytochrome P450 3A polymorphisms and immunosuppressive drugs:: an update
    Anglicheau, Dany
    Legendre, Christophe
    Beaune, Philippe
    Thervet, Eric
    [J]. PHARMACOGENOMICS, 2007, 8 (07) : 835 - 849
  • [3] IL-6 promoter polymorphism-174 is associated with new-onset diabetes after transplantation
    Bamoulid, Jamal
    Courivaud, Cecile
    Deschamps, Marina
    Mercier, Patricia
    Ferrand, Christophe
    Penfornis, Alfred
    Tiberghien, Pierre
    Chalopin, Jean-Marc
    Saas, Philippe
    Ducloux, Didier
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (08): : 2333 - 2340
  • [4] Influence of donor C3 allotype on late renal-transplantation outcome
    Brown, KM
    Kondeatis, E
    Vaughan, RW
    Kon, SP
    Farmer, CKT
    Taylor, JD
    He, X
    Johnston, A
    Horsfield, C
    Janssen, BJC
    Gros, P
    Zhou, WD
    Sacks, SH
    Sheerin, NS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (19) : 2014 - 2023
  • [5] ABCB1 Genotypes Predict Cyclosporine-Related Adverse Events and Kidney Allograft Outcome
    Cattaneo, Dario
    Ruggenenti, Piero
    Baldelli, Sara
    Motterlini, Nicola
    Gotti, Eliana
    Sandrini, Silvio
    Salvadori, Maurizio
    Segoloni, Giuseppe
    Rigotti, Paolo
    Donati, Donato
    Perico, Norberto
    Remuzzi, Giuseppe
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (06): : 1404 - 1415
  • [6] Genetic diagnosis by whole exome capture and massively parallel DNA sequencing
    Choi, Murim
    Scholl, Ute I.
    Ji, Weizhen
    Liu, Tiewen
    Tikhonova, Irina R.
    Zumbo, Paul
    Nayir, Ahmet
    Bakkaloglu, Aysin
    Ozen, Seza
    Sanjad, Sami
    Nelson-Williams, Carol
    Farhi, Anita
    Mane, Shrikant
    Lifton, Richard P.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (45) : 19096 - 19101
  • [7] A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke
    Cipollone, F
    Toniato, E
    Martinotti, S
    Fazia, M
    Iezzi, A
    Cuccurullo, C
    Pini, B
    Ursi, S
    Vitullo, G
    Averna, M
    Arca, M
    Montali, A
    Campagna, F
    Ucchino, S
    Spigonardo, F
    Taddei, S
    Virdis, A
    Ciabattoni, G
    Notarbartolo, A
    Cuccurullo, F
    Mezzetti, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (18): : 2221 - 2228
  • [8] Screening the human exome: a comparison of whole genome and whole transcriptome sequencing
    Cirulli, Elizabeth T.
    Singh, Abanish
    Shianna, Kevin V.
    Ge, Dongliang
    Smith, Jason P.
    Maia, Jessica M.
    Heinzen, Erin L.
    Goedert, James J.
    Goldstein, David B.
    [J]. GENOME BIOLOGY, 2010, 11 (05):
  • [9] TOXICITY OF CYCLOSPORINE METABOLITES
    COPELAND, KR
    THLIVERIS, JA
    YATSCOFF, RW
    [J]. THERAPEUTIC DRUG MONITORING, 1990, 12 (06) : 525 - 532
  • [10] Pharmacogenetics of Calcineurin Inhibitors in Renal Transplantation
    Coto, Eliecer
    Tavira, Beatriz
    [J]. TRANSPLANTATION, 2009, 88 (03) : S62 - S67